机构：[1]Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China[2]Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China[3]Department of Breast Cancer, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510000, China广东省中医院[4]Department of Breast Head and Neck Surgery, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, China[5]Department of Breast Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510062, China中山大学附属第一医院[6]Department of Breast Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, China[7]Department of Oncology, General Hospital of Ningxia Medical University, Ningxia 750003, China[8]Department of Breast Surgery, the First Hospital of Jilin University, Changchun 130031, China[9]Department of Oncology Surgery, the Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou 310009, China[10]Department of Oncology, Nanchang Third Hospital, Nanchang 330009, China[11]Department of Breast Surgery, Shanxi Cancer Hospital, Taiyuan 030013, China[12]Department of Breast Surgery, Yunnan Cancer Hospital, Kunming 650118, China[13]Department of Breast Surgery, Jilin Cancer Hospital, Changchun 130012, China[14]Department of Oncology, Cancer Hospital Affiliated to the University of Chinese Academy of Sciences, Hangzhou 310005, China浙江省肿瘤医院[15]Department of Oncology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China[16]Department of Oncology, Liaoning Cancer Hospital, Shenyang 110801, China[17]Department of Oncology, Tumor Hospital of Tianjin Medical University, Tianjin 300060, China[18]Department of Breast Surgery, Sichuan Provincial People's Hospital, Chengdu 610042, China四川省人民医院[19]Department of Breast Cancer, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China河北医科大学第四医院[20]Department of Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116050, China[21]Department of Head and Neck Tumor, West China Hospital of Sichuan University, Chengdu 610042, China四川大学华西医院[22]Department of Breast Surgery, the First Hospital of Peking University, Beijing 100034, China.
In this study, we aimed to explore the safety and vaccination coverage data of Chinese patients with breast cancer receiving coronavirus disease 2019 (COVID-19) vaccination. The patients were recruited from 41 hospitals across 20 Chinese provinces. The vaccination coverage was approximately 22.4%, and the frequency of total adverse events was 13.3% after the first dose and 9.9% after the second dose. The most frequent adverse reaction within 14 days of the first dose was local pain (5.7%). Unvaccinated patients were very likely to reject the vaccine rather than be hesitant in patients with old age (odds ratio [OR], 1.238; 95% confidence interval [CI], 1.101-1.391), chronic disease history (OR, 1.189; 95% CI, 1.057-1.337), and cancer relapse (OR, 1.398; 95% CI, 1.233-1.585). Of the unvaccinated patients with breast cancer, 54.1% opted to receive COVID-19 vaccines if more data were available. Considering the safety but low vaccination coverage for breast cancer, increased positive attitudes and acceptance toward COVID-19 vaccines are important.
基金：
Emergency Key Program of Guangzhou Laboratory [EKPG21-30-4]
语种：
外文
被引次数：
WOS：
中科院分区：
出版当年[2023]版：
无
最新[2025]版：
大类|4 区医学
小类|4 区传染病学
第一作者：
第一作者机构：[1]Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Shaohua,Li Jianbin,Xu Ruonan,et al.Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China[J].INFECTIOUS DISEASES & IMMUNITY.2023,3(3):127-131.doi:10.1097/ID9.0000000000000090.
APA：
Zhang, Shaohua,Li, Jianbin,Xu, Ruonan,Chen, Qianjun,Sun, Gang...&Jiang, Zefei.(2023).Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China.INFECTIOUS DISEASES & IMMUNITY,3,(3)
MLA：
Zhang, Shaohua,et al."Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China".INFECTIOUS DISEASES & IMMUNITY 3..3(2023):127-131
